Brief: Brenntag - Brenntag Specialties Acquires Mcepharma
June 4 (Reuters) - BRENNTAG SE BNRGn.DE: BRENNTAG SPECIALTIES ACQUIRES MCEPHARMA TO CREATE UNIQUE POSITION TO SERVE FAST GROWING DEMAND IN BIOPHARMA MARKET WITH GMP VALUE ADDED SERVICES FINANCIAL DETAILS OF THE DEAL ARE NOT BEING DISCLOSED. SIGNING AND CLOSING OF THE TRANSACTION OCCURRED SIMULTANEOUSLY. Further company coverage: [BNRGn.DE] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Brenntag SE
See all newsLive Markets: Disregard European chemicals' Q2 earnings beats
Live Markets: Before the bell: Tech selloff to drag Europe lower
Brenntag rises in early Frankfurt trade after guidance hike
Brenntag lifts full-year operating profit outlook on strong demand, improved margins
Brief: Brenntag Publishes Preliminary Operating EBITDA For The Second Quarter Of 2026